miércoles, 25 de septiembre de 2024

Drug Trials Snapshots: XACDURO (sulbactam for injection; durlobactam for injection), co-packaged for intravenous use

XACDURO is an antibacterial drug to treat adults who have hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) caused by specific bacteria called Acinetobacter baumannii-calcoaceticus complex. It should not be used to treat pneumonia, which is caused by other bacteria. https://www.fda.gov/drugs/drug-approvals-and-databases/drug-trials-snapshots-xacduro

No hay comentarios:

Publicar un comentario